Chemical Manufacturing in Eastern Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Eastern Europe chemical manufacturing market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The chemical manufacturers industry is defined as the total production of chemicals manufactured in the stated country or region.
*The Eastern European chemical manufacturing industry had total revenue of $83.3 billion in 2010, representing a compound annual growth rate (CAGR) of 2.9% for the period spanning 2006-2010.
*The basic chemicals segment was the industry's most lucrative in 2010, with total revenue of $40.6 billion, equivalent to 48.8% of the industry's overall value.
*The performance of the industry is forecast to accelerate, with an anticipated CAGR of 4.1% for the five-year period 2010-2015, which is expected to drive the industry to a value of $101.7 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the chemical manufacturing market in Eastern Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the chemical manufacturing market in Eastern Europe
Leading company profiles reveal details of key chemical manufacturing market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Eastern Europe chemical manufacturing market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Eastern Europe economy
Key Questions Answered
What was the size of the Eastern Europe chemical manufacturing market by value in 2010?
What will be the size of the Eastern Europe chemical manufacturing market in 2015?
What factors are affecting the strength of competition in the Eastern Europe chemical manufacturing market?
How has the market performed over the last five years?
What are the main segments that make up Eastern Europe's chemical manufacturing market?
Introduction
Chemical Manufacturing in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metri ... more
Introduction
Chemical Manufacturing in Eastern Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metr ... more
Introduction
Chemical Manufacturing in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metri ... more
As pay-for-delay agreements look to be on the way out of the pharmaceutical industry in Europe and the US, a new report by independent market analyst Datamonitor forecasts that the number of authorized generics (AG) agreements will grow, in tandem with the increasing convergence between bra ... more
As part of the UK government’s drive to save £2.3 billion ($3.4 billion) in the National Health Service (NHS) during 2010–11, £550m ($800m) will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme (PPRS) included in Alistair Darling’s 20 ... more
In recent years, Pharma has begun to adapt its business model in response to growing industry constraints and the decline of primary-care focused blockbuster therapy. This process of change has recently been disrupted by unprecedented challenges caused by the global economic downturn and Pr ... more